Position in BEAM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$201,149
+$41,226 QoQ
Shares Held
5,861
-12.7% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#190
of 274 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BEAM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,111,483,806 across 123 Biotechnology names. BEAM ranks #100 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in BEAM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $201,149 | 5,861 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $159,923 | 6,711 | Shares | Sole | 2026-08-18 | |
| 2025-12-31 | $186,028 | 6,711 | Shares | Sole | 2026-08-18 | |
| 2025-09-30 | $509,936 | 21,011 | Shares | Sole | 2026-08-18 | |
| 2025-06-30 | $495,178 | 29,111 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $568,537 | 29,111 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $721,952 | 29,111 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $713,219 | 29,111 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $682,070 | 29,111 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $961,827 | 29,111 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $832,387 | 30,580 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $735,449 | 30,580 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $976,419 | 30,580 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $867,464 | 28,330 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $998,478 | 25,530 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $654,097 | 13,730 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,883,391 | 74,487 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $483,612 | 8,440 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $672,583 | 8,440 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,352,228 | 27,034 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,479,546 | 27,034 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,163,801 | 27,034 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $9,821,863 | 120,307 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,620,439 | 65,818 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $796,656 | 28,452 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $622,908 | 34,606 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||